Claritine

Medicinal product

(Invented) name

Claritine

Active substance (s)

Loratadinas

Strength

10 mg

Pharmaceutical form

tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Nereceptinis/Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

R06AX13, Loratadine

Marketing authorisation holder

UAB Niromed, Lietuva

Date of authorisation

2025-04-03

Date of renewal

Documents

2454_Claritine 10mg_tab_Rp_PZ_2025-04-03.docx

2454_Claritine 10mg_tab_NeRp_PZ_2025-04-03.docx

2454_Claritine 10mg_tab_PL_2025-04-03.docx

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

Procedure number

Marketing authorisation procedure

Lygiagretus importas

Qualitative and quantitative composition

Tabletėje yra:	1 vnt.
Loratadinas	10 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
117143	103243	1103243	lizdinė plokštelė	N10		Nereceptinis	LT/L/25/2454/001	Netiekiama	-	-	No	-	-	Download
117144	103244	1103244	lizdinė plokštelė	N30		Receptinis	LT/L/25/2454/002	Netiekiama	-	-	No	-	-	Download

Stadijos

Data	Stadija
2025-04-03	Registruotas